Single-cell landscape of bronchoalveolar immune cells in patients with immune checkpoint inhibitor-related pneumonitis
Open Access
- 5 October 2024
- journal article
- research article
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-13
Abstract
The pathophysiology of immune checkpoint inhibitor-related pneumonitis remains incompletely understood. We conducted single-cell and T-cell receptor transcriptomic sequencing on the bronchoalveolar lavage fluid from five patients with grade ≥2 immune checkpoint inhibitor-related pneumonitis. Our analyses revealed a prominent enrichment of T cells in the bronchoalveolar lavage fluid of patients with immune checkpoint inhibitor-related pneumonitis. Within the CD4 + T cell subset, Tfh-like T cells were highly enriched and exhibited signatures associated with inflammation and clonal expansion. Regulatory T cells were also enriched and displayed enhanced inhibitory functions. Within the CD8 + T-cell subset, effector memory/tissue-resident memory T cells with an elevated cytotoxic phenotype were highly infiltrated. Among myeloid cells, alveolar macrophages were depleted, while pro-inflammatory intermediate monocytes were elevated. Dendritic cells demonstrated enhanced antigen presentation capabilities. Cytokines CXCR4, CXCL13, TNF-α, IFN-α, IFN-γ, and TWEAK were elevated. Through a comprehensive single-cell analysis, we depicted the landscape of immune checkpoint inhibitor-related pneumonitis.Keywords
This publication has 32 references indexed in Scilit:
- Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic ReviewsDrugs, 2022
- The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseasesInternational Immunopharmacology, 2022
- Hallmarks of response, resistance, and toxicity to immune checkpoint blockadeCell, 2021
- Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control studyJournal of Cancer Research and Clinical Oncology, 2021
- Understanding and treating the inflammatory adverse events of cancer immunotherapyCell, 2021
- TWEAK/Fn14 axis in respiratory diseasesClinica Chimica Acta, 2020
- The role of macrophages type 2 and T-regs in immune checkpoint inhibitor related adverse eventsImmunobiology, 2020
- Molecular Pathways of Colon Inflammation Induced by Cancer ImmunotherapyCell, 2020
- Fatal Toxic Effects Associated With Immune Checkpoint InhibitorsJAMA Oncology, 2018
- Immune Checkpoint Immunotherapy for Non-Small Cell Lung CancerChest, 2018